We are live on ! Find out more
NRXS icon

Neuraxis

18 hedge funds and large institutions have $6.88M invested in Neuraxis in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

176% more capital invested

Capital invested by funds: $2.49M → $6.88M (+$4.39M)

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

6.57% more ownership

Funds ownership: 8.2%14.76% (+6.6%)

0% more funds holding

Funds holding: 1818 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

Holders
18
Holders Change
Holders Change %
0%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
4
Reduced
2
Closed
5
Calls
Puts
Net Calls
Net Calls Change

NRXS Hedge Fund Activity: Q4 2025 in Review

18 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in Neuraxis (NRXS) for Q4 2025, worth a combined $6.88M — up 176% from $2.49M a quarter earlier.

Fund positioning in NRXS was balanced in Q4 2025: 5 funds opened new positions, 5 closed out, 4 added to existing stakes and 2 trimmed.

The largest buyer was Rosalind Advisors, opening a new position worth an estimated $855K. The largest seller was Citadel Advisors, exiting entirely with an estimated $110K sold.

  • 18 institutional investors held Neuraxis (NRXS) as of Q4 2025, unchanged from Q3 2025.
  • Funds reported $6.88M of Neuraxis stock for Q4 2025, up 176% quarter-over-quarter.
  • 5 funds opened new Neuraxis positions in Q4 2025 and 5 closed out, a net change of 0 holders.
  • The largest Neuraxis buyer in Q4 2025 was Rosalind Advisors, an estimated $855K added.
  • The largest Neuraxis seller in Q4 2025 was Citadel Advisors, an estimated $110K sold.

Based on aggregated 13F filings for Q4 2025.